We provide you with 20 years of free, institutional-grade data for OKYO stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of OKYO. Explore the full financial landscape of OKYO stock.
| Reported Date | CIK | Ticker | Type |
|---|
OKYO Pharma(NASDAQ:OKYO) 
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-...
Website: https://www.okyopharma.com
Founded: 2007
IPO Price: $4 (May 17, 2022)
Full Time Employees: 6
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report about OKYO stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.